Live Breaking News & Updates on Annual Neuroscience Innovative

Stay updated with breaking news from Annual neuroscience innovative. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Appendix 4C – Q3 FY23 Quarterly Cash Flow Report

Highlights: Continued expansion of ATH434 Phase 2 Clinical Trial with sites open for recruitment in five countriesParticipants in the US and Europe. ....

United States , San Francisco , Vanderbilt University , David Stamler , Investorand Mediacontacts , Hannah Howlett , Remy Bernarda , Alterity Therapeutics , Vanderbilt University Medical Center , Securities Exchange , Sachs Associates , Neuroscience Innovative Forum , Alterity Therapeutics Limited , Annual Neuroscience Innovative , Therapeutics Limited , Quarterly Cash Flow Report , Multiple System Atrophy , Chief Executive Officer , Licensing Agreement , Professor Colin Masters , American Depository Shares , Ordinary Shares , Securities Act , Securities Exchange Act , Australian Stock Exchange Ath Ax , Alterity Therapeutics Limited ,